Uveitis is uncommon but not extremely rare. Depending on how it’s measured, somewhere between 1 and 5 out of every 1,000 adults in the United States have had it at some point in their lives. That makes it far less common than conditions like diabetes or high blood pressure, but significantly more common than diseases that carry an official “rare disease” designation (which requires fewer than 200,000 total cases nationwide).
Prevalence by the Numbers
Studies measuring uveitis prevalence in the U.S. have produced a range of estimates, largely because they measure different things. Earlier research looking at cases diagnosed within a single year found roughly 115 to 121 cases per 100,000 adults. That’s the number of people actively dealing with uveitis at any given time.
A nationally representative study using NHANES data took a different approach, asking adults ages 20 to 69 whether they’d ever been diagnosed with uveitis. That lifetime prevalence came in much higher: about 5.4 per 1,000 people, or roughly 1 in 185 adults. Even when the researchers narrowed it to only those who had received treatment (a stricter way to confirm the diagnosis), the estimate was still 3.4 per 1,000. The gap between the two types of estimates makes sense. Uveitis often flares and then resolves, so many people who’ve had it aren’t actively symptomatic in any given year.
It’s Rarer in Children
Pediatric uveitis is genuinely uncommon. Children account for only 5% to 10% of all uveitis cases. When uveitis does occur in kids, it tends to look different from the adult version. More than half of childhood cases in some countries have no identifiable cause, a higher rate of “idiopathic” disease than what’s seen in adults. This can make diagnosis slower, since there’s no obvious underlying condition pointing toward the eyes.
Which Type You Have Matters
Uveitis is classified by which part of the eye is inflamed, and the types vary dramatically in how common they are. Anterior uveitis, affecting the front of the eye, is by far the most frequent. In one Canadian referral center’s data, anterior cases outnumbered intermediate cases (which affect the middle of the eye) by nearly 9 to 1, and panuveitis (inflammation throughout the entire eye) was rarer still. Posterior uveitis, affecting the back of the eye near the retina, and panuveitis tend to be more serious and harder to treat, but they’re also the least common forms.
Most Cases Are Autoimmune, Not Infectious
In developed countries, 67% to 90% of uveitis cases are non-infectious, meaning the inflammation comes from the immune system attacking the eye’s own tissue rather than from a virus or bacteria. The single most common identified trigger is a genetic marker called HLA-B27, which is also linked to conditions like ankylosing spondylitis (a type of inflammatory arthritis affecting the spine).
About 30% of all uveitis cases are connected to a broader systemic disease. In some people, uveitis is actually the first visible sign that something autoimmune is happening elsewhere in the body. This is particularly notable with multiple sclerosis: uveitis appears before MS is diagnosed in nearly half of cases where the two conditions overlap. Other associated conditions include sarcoidosis and Behçet disease. The remaining 20% to 30% of cases are idiopathic, meaning no underlying cause is ever identified.
Why Rarity Doesn’t Mean Low Impact
Even though uveitis affects a relatively small slice of the population, it punches above its weight when it comes to vision loss. It accounts for 10% to 20% of blindness in the United States and Europe, and possibly up to 25% in developing countries. That’s a disproportionate share for a condition most people have never heard of.
The risk of serious vision loss varies by type. In one large study, about 1% of people with anterior uveitis (the most common and generally mildest form) met criteria for blindness in at least one eye. For non-anterior uveitis, that figure was roughly 0.5%, though the study used a stricter definition of blindness than many countries apply. The real danger often comes from delayed diagnosis or inadequate treatment of chronic or recurring inflammation, which can gradually damage structures inside the eye over months or years.
Who Gets It
Uveitis can strike at any age, but it’s most commonly diagnosed in working-age adults, roughly between ages 20 and 60. It affects both men and women, though certain subtypes skew toward one gender. The condition occurs across all ethnic groups, though the specific causes vary by population. HLA-B27-associated uveitis is more common in people of European descent, while Vogt-Koyanagi-Harada disease (a type that causes panuveitis) is more frequently seen in people of Asian, Hispanic, or Middle Eastern background.
If you’ve been diagnosed with uveitis, you’re in an uncommon but far from tiny group. The condition is common enough that most ophthalmologists see it regularly and have well-established treatment approaches, but uncommon enough that you may need a specialist in ocular immunology for anything beyond a straightforward first episode of anterior uveitis.